Promaxo

Promaxo

  • Founded in 2021
  • 11-50 Employees
  • $4.2M Corporate Round on 2021-01

Careers at Promaxo


About Promaxo

Promaxo is a company focused on advancing cancer care through innovative technology. Their specialized MRI system is designed to identify aggressive prostate cancer earlier, offering peace of mind to patients. Promaxo utilizes cutting-edge imaging, artificial intelligence, and robotic technologies to enhance prostate cancer detection and treatment. Their MRI systems are compact, easy to install, and fit seamlessly into existing clinical workflows, allowing physicians to conduct MRI-guided prostate biopsies and treatments in-office without extensive facility upgrades. Promaxo's technology aims to provide personalized prostate cancer care with increased diagnostic confidence and precision.